Suchergebnisse - "VanLunen, Brenda"

PubPharm (14)

1

Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe

enthalten in: Rheumatology (Oxford, England) | 2021

von Baraliakos, X. | Witte, T. | De Clerck, L. | +8

2

A multicenter, open-label study to evaluate the safe and effective use of a new electromechanical auto-injection device for self-injection of certolizumab pegol

enthalten in: Expert opinion on drug delivery | 2020

von Tatla, D. | Mountian, I. | Szegvari, B. | +2

3

The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis : 48-week interim results from C-VIEW

enthalten in: RMD open | 2020

von van der Horst-Bruinsma, I. | van Bentum, R. | Verbraak, F. | +8

4

A multicenter, open-label study to evaluate the safe and effective use of a new electromechanical auto-injection device for self-injection of certolizumab pegol

enthalten in: Expert opinion on drug delivery | 2020

von Tatla, D. | Mountian, I. | Szegvari, B. | +2

5

A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2017

von Weinblatt, M. | Bingham, C. | Burmester, G. | +9

6

Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis

enthalten in: Expert opinion on drug delivery | 2017

von Domańska, B. | VanLunen, B. | Peterson, L. | +2

ErratumIn: Expert Opin Drug Deliv. 2017 Mar;14 (3):447. - PMID 28110560

7

Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis

enthalten in: Expert opinion on drug delivery | 2017

von Domańska, B. | VanLunen, B. | Peterson, L. | +2

8

Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis

enthalten in: Expert opinion on drug delivery | 2017

von Domańska, B. | VanLunen, B. | Peterson, L. | +2

9

A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis

enthalten in: Arthritis & Rheumatology | 2017

von Weinblatt, M. | Bingham, C. | Burmester, G. | +9

10

Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis

enthalten in: Expert opinion on drug delivery | 2016

von Domańska, B. | VanLunen, B. | Peterson, L. | +2